导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.09% | 4211/4773 |
| 近一周 | -2.42% | 3849/5465 |
| 近一月 | -7.86% | 4705/5421 |
| 近一季 | -22.85% | 5099/5231 |
| 近半年 | -29.73% | 4908/4920 |
| 近一年 | -11.29% | 3487/4394 |
| 近两年 | 24.14% | 2543/2954 |
| 近三年 | -19.48% | 2155/2253 |
| 成立以来 | 16.53% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.40% 171/4961 |
0.98% 3087/5312 |
- - |
- - |
| 2025 | 26.90% 1593/4813 |
-5.59% 3302/3635 |
-5.95% 3603/4076 |
41.69% 720/4524 |
0.87% 1700/4813 |
| 2024 | -14.67% 2451/3463 |
-5.94% 1982/2808 |
-18.67% 2785/3014 |
21.95% 525/3129 |
-8.53% 2864/3463 |
| 2023 | -35.31% 2134/2656 |
-2.53% 2009/2280 |
-7.08% 1770/2385 |
-18.78% 2351/2515 |
-12.06% 2448/2655 |
| 2022 | -19.58% 869/2207 |
-17.83% 1269/1919 |
20.59% 42/2016 |
-12.86% 795/2113 |
-6.86% 2022/2208 |
| 2021 | 50.24% 3/1822 |
-7.64% 1066/1255 |
28.94% 50/1330 |
24.85% 25/1466 |
1.04% 1018/1822 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 华泰柏瑞中证光伏产业ETF VS. 长安沪深300非周期A(740101) |